CD8A and neoplasm: For instance, a study using an oncolytic herpes simplex virus encoding IL-12 in TNBC models observed significant tumor regression at both local and distant sites, driven by CD8+ T cell infiltration and the recruitment of DCs that facilitate tumor antigen presentation and systemic immune activation [60].